CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a metabolic signature for neuroendocrine tumors (NENs) to improve patient stratification based on tumor site and malignancy. By utilizing advanced spectroscopy and spectrometry techniques, the study seeks to enhance understanding of NENs and address the rising incidence of these tumors.
Background:
Tumors that arise from neuroendocrine cells (NENs) were traditionally considered rare tumors with low malignant potential.
Recent data suggest that the incidence of NENs has increased over the last three decades.
Furthermore, symptoms are frequently overlooked and subsequently, 60-80% of these tumors present with metastases at initial diagnosis.
The common denominator of these tumors is their neuroendocrine origin; however, they demonstrate remarkable diversity, unique properties and…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
